DEAD SPACE MEASUREMENT IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME DUE TO COVID-19 INFECTION

Brief description of study

The purpose of this study is to monitor and explore how respiratory mechanics affects outcomes in critically ill patients diagnosed with acute respiratory distress syndrome (ARDS) due to COVID-19. Respiratory mechanics will be monitored using a device called a bedside volumetric capnograph (NICO2, Philis-Respironics). The NICO2 is currently approved by the U.S. Food and Drug Administration and used in many hospitals.


Clinical Study Identifier: s20-00662
Principal Investigator: David A. Kaufman.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.